Loading data for CANF — first visit, this takes a few seconds.
Can-Fite BioPharma Ltd. (CANF)
NYSE American: CANF
· 실시간 가격 · USD
3.45
-0.13 (-3.63%)
종가 기준: Aug 18, 2026, 3:52 PM
3.45
+2.55%
프리마켓: 6:43 AM
Can-Fite BioPharma Ltd. (CANF) Stock Price, Analysis & Data
-3.63% (1D)
CANF 소개
Can-Fite BioPharma Ltd., a clinical-stage biopharmaceutical company, develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver inflammatory diseases, and erectile dysfunction in Israel. The company's lead drug candidate Piclidenoson, which has been completed Phase III clinical trial for the treatment of psoriasis. It develops Namodenoson that is in Phase III clinical trial for the treatment of liver cance...
전체 기업 정보재무 실적
2025년 Can-Fite BioPharma의 매출은 405K로, 전년 674K 대비 -39.91% 감소했습니다. 순이익은 -9.83M로, 24.72% 증가했습니다.
재무제표어닝 서프라이즈
Can-Fite BioPharma가 Mar 28, 2024에 분기 실적을 발표했습니다:
2 페이지 중 1
